SlideShare a Scribd company logo
1 of 55
Download to read offline
Dr. Prasoon Rastogi
MD Med.
Case 1 :
A 54-year-old woman presented with chronic cough with thick
greenish sputum that has worsened over a period of 6–12
months. Over the course of the day, she estimates that she
produces as much as 100 ml of sputum daily. Bilateral coarse
crackles are heard in the lower lung zones. Pulmonary function
tests demonstrate FEV1/FVC ratio of 56%. A chest radiograph is
unremarkable. What would you recommend as the next step in
the evaluation and management of this patient?
Case 2:
A 48-year-old man(chronic alcoholic) presented with fever and
cough. He has fever, fatigue and generalized malaise for about 8
weeks. During this period, he has been having increasing cough
with foul smelling dark sputum production at least 3 tablespoons
daily that has been blood streaked at times. He has evidence of
temporal wasting with very poor dentition. A foul odor is present
on his breath. Amphoric breath sounds are heard posteriorly in
the right lower lung field. What is the best initial choice for
therapy in this patient and investigations to be planned ?
At the end of this presentation we would be able to:
1. Know the different types of suppurative lung diseases.
2. Describe the etiology and pathogenesis of each type.
3. Describe the clinical features of each disease.
4. Interpret the specific investigations.
5. Discuss the different complications.
6. Discuss the treatment modalities including surgery.
The term suppurative lung diseases implies the following:
 Bronchiectasis
 Lung abscess
 Empyema thoracis
History
Fever, persistent cough with copious sputum production
Weeks to months
+
Risk of aspiration
GERD
Tooth infections (bad breath)
Months to years
+
h/o recurrent/long standing infections
Postural increase in sputum production
Congenital defects
Autoimmune disorder
Rhinosinusitis
Examination
Auscultation:
Wheezing + coarse
crepts
General : mouth
for decaying teeth,
gag reflex may be
absent.
Palpation :
increased vocal
fremitus
Percussion :
dullness
Auscultation :
Amphoric or
cavernous sounds
General: mouth for
decaying teeth
Inspection : restricted
movement, Crowding
of ribs
Palpation :
tracheal shift ± shifting
of apex beat
Decreased Vocal
fremitus
Reduced chest
expansion
Auscultation
Decreased/absent
breath sounds
Decreased/ absent
vocal resonance
Bronchiectasis
 Abnormal irreversible dilatation of the bronchi (medium sized
bronchioles).
 Not a disease per se but end stage of a variety of pathological
processes.
 Extent may focal (localized to an area distal to mechanical
bronchial obstruction) or diffuse (systemic pathology).
Etiology:
I. Post infectious
II. Mucociliary abnormalities
III. Immunological disorders
IV. Mechanical Obstruction
Post infectious
Bacterial
Viral
Fungi
Mucociliary
abnormalities
Kartagener’s
Syndrome
Young’s Syndrome
Cystic Fibrosis
Immunological
disorders
Immunodeficiency
Autoimmune
disorders
Hyper-immune
response (ABPA)
Clinical Features:
Symptoms:
1. Persistent cough with expectoration
2. Copious thick sputum associated with postural change.
3. Haemoptysis (30%)
4. Dyspnea
5. Chest pain
Signs:
1. Crepitations (78%)
2. Wheezes (20%)
3. Signs of pulmonary hypertension or corpulmonale.
4. General: Cyanosis, clubbing(5%)
Associated findings supporting the diagnosis
Signs and Symptoms suggestive of -
 Rhinosinusitis
 Gastro-esophageal reflux Disease
 Depressed sensorium
 Autoimmune disease
 Mucociliary defect
 ABPA (Allergic Brochopulmonary Aspergillosis)
 Primary immunodeficiency
Diagnosis and investigations:
 Sputum – culture & sensitivity
Common organisms:
H.Infleunza.
S.Pneumoniae.
Pseudomonas aeruginosa
S.Aureus.
Mycobacterium sp.
Chest X ray
HRCT(High Resolution Computed Tomography)
Radiological clues to etiology –
 Chronic recurrent aspirations – lower lung fields
 MAC infection - middle lung fields
 Congenital cilliary defects – middle lung field
 Allergic Bronchopulmonary Aspergillosis – central bronchioles
 Cystic fibrosis & radiation – upper lung fields
Tests for Detecting Specific Aetiologies of
Bronchiectasis
 Paranasal sinus disease (X-ray or CT paranasal sinuses)
 Gastro-oesophageal reflux (barium swallow, esophageal manometry)
 Immune deficiency [Total levels of IgG, IgM, IgE and IgA]
 ABPA [serum precipitins and sputum for Aspergillus fumigatus]
 Connective tissue disorders ( ANA and rheumatoid factor)
 α1-antitrypsin deficiency (serum α1-antitrypsin levels)
 Cystic fibrosis (sweat chloride analysis, genotyping)
 Endobronchial abnormalities (Fibre-optic bronchoscopy)
 Ciliary dyskinesias (semen analysis, saccharine test)
 Functional impairment :
1. Measurement of ventilatory capacity
 Airway obstruction.
 Lung volumes and compliance.
2. Gas exchange studies
 Decreased DLCO.
 Abnormal V/P scan.
Treatment
Medical
Antibiotics Bronchial hygiene Corticosteroids Prevention
Surgical
Antibiotics
Indications:
1. Mucoid sputum  muco-purulent sputum.
2. Chronic muco-purulent or purulent sputum  ↑ amount or
purulence, change of color, systemic symptoms or
worsening of lung functions.
Antibiotic therapy
 Start with β lactum antibiotics preferably with pseudomonal
coverage.
 Add antibiotics according to culture and sensitivity.
 Duration – 7-10 days(acute exacerbations) upto 14 days.
Bronchial hygiene
Aim:
 Mobilization of secretions from the lung periphery (or
affected area)towards the more central unaffected segments
in which cough reflex is intact and mucociliary function is
preserved.
Approaches :
 Hydration and mucolytic administration
 Brochodilators
 Chest physiotherapy
Complications
1. Recurrent pneumonia.
2. Lung abscess.
3. Pneumothorax.
4. Cor pulmonale and pulmonary hypertension
5. Secondary Amyloidosis.
Lung Abscess
Localized area of destruction of lung parenchyma where
pyogenic infection is the cause of tissue necrosis and suppuration.
 Primary lung abscesses - arise from aspiration (anaerobic
bacteria), absence of an underlying pulmonary or systemic
condition.
 Secondary lung abscesses – underlying pulmonary
condition(postobstructive e.g. a bronchial foreign body or
tumor) or a systemic process (e.g., HIV infection or another
immunocompromising condition).
Primary lung abscess
1. Factors predisposing to aspiration
 Dental caries
 Impaired consciousness
 Anaesthesia (general)
 Stroke (cerebro-vascular accident)
 Seizures including post-ictal state
 Head trauma
 Alcohol intoxication
 Drug overdose or abuse (narcotics, sedatives)
 Metabolic encephalopathy
 Neuromuscular diseases
2. Oesophageal disorders
 Achalasia and other dysmotility syndromes
 Gastro-oesophageal reflux
 Stricture (benign or malignant)
 Zenker’s diverticulum
Clinical features
Symptoms: chronic indolent course
1. Fever
2. Cough with expectoration(copious & foul smelling)
3. Chest pain.
4. Hemoptysis.
5. Dyspnea
6. Fatigue, night sweats and anemia.
Signs:
General: clubbing, mouth for decaying teeth, gag reflex may
be absent.
Palpation : increased vocal fremitus
Percussion : dullness
Auscultation :
 amphoric or cavernous sounds
Anaerobic organisms
Prevotella
spp.
Fusobacterium
nucleatum
Peptostreptococci
spp.
Common organisms
Aerobic
organisms
G +ve
Strep. melleri
Strep. pneum.
Staph aureus
G –ve
Pseudomonas
Klebsiella
E.coli
H.Infleunza
Investigations:
Microbiological studies:
1. Sputum
 Gram stain
 Culture
2. Blood culture
3. Specimens for anaerobic culture without oropharyngeal
contamination
 Transtracheal aspiration
 Percutaneus Needle Aspiration
 Brochoalveolar lavage
Chest X Ray
CECT Thorax
 Other investigations
1. Bronchoscopy
2. Upper GI endoscopy
Complications
1. Pneumatocoeles (persistent cystic changes)
2. Bronchiectasis
3. Empyema
4. Direct or haematogenous spread.
5. Massive hemoptysis
Treatment
1. Antibiotics
 Duration - 3-4 weeks( upto 14 weeks) – non tubercular
2. Bronchoscopy
3. Surgery
 Abscess > 6 – 8 cm in diameter
 Non responders to antibiotic treatment
Antibiotics
Community
acquired
Clindamycin Amoxicillin +
Clavulanic acid
Hospital
acquired
To cover:
G–ve, staph &
anaerobe
Empyema thoracis
 Definition:
Pus in the pleural cavity
 Etiology:
1.Thoracic & extrathoracic infection
2.Tumour
3.Trauma or iatrogenic
Infections
Thoracic
Pulmonary: TB,
Pneumonia,
Bronchiectasis
Mediastinitis
Extrathoracic
Liver or
subphrenic
abscess
Common organisms:
1. Anaerobes
2. Staph. aureus
3. β hemolytic streptococci
4. Pseudomonas, E. coli & Klebsiella spp.
5. Mixed.
Clinical picture:
Symptoms
1. Fever
2. Malaise
3. Pleuritic chest pain
4. Dyspnea
5. Cough  sputum
Signs
General: weight loss, clubbing, mouth for decaying teeth
Inspection : restricted movement, Crowding of ribs
Palpation :
 tracheal shift
shifting of apex beat
 Vocal fremitus
 Reduced chest expansion
Auscultation
 Decreased breadth sounds
 Decreased/ absent vocal resonance
 No added sounds
Investigations:
1. Blood and biochemical exam
2. Chest radiograph
3. CT scan
4. Sputum culture
5. Blood culture
6. Usg guided thoracocenthesis:
 Chemistry
 Bacteriology
 Cytology
8. Bronchoscopy
Management
(Antibiotics + Drainage)
Antibiotics
 Same as lung abscess
Drainage
 10 –20% require external drainage or surgery.
Drainage
Closed
Frank pus
ph < 7
Failure to improve
Bronchopleural fistula
Open drainage
with rib resection
Decortication
Complications
 Restrictive defect
 Pleural calcifications
 Brochopleural fistula
 Pleuro-cutaneous fistula
 Pleural thickening
Approach to a case of suppurative lung disease

More Related Content

What's hot

What's hot (20)

Pneumonia
PneumoniaPneumonia
Pneumonia
 
12.Respiratory Failure
12.Respiratory Failure12.Respiratory Failure
12.Respiratory Failure
 
dyspnea approach
dyspnea approachdyspnea approach
dyspnea approach
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Chronic obstructive pulmonary disease ppt
Chronic obstructive pulmonary disease   pptChronic obstructive pulmonary disease   ppt
Chronic obstructive pulmonary disease ppt
 
Inflammatory bowel disease,
Inflammatory bowel disease,Inflammatory bowel disease,
Inflammatory bowel disease,
 
Suppurative lung diseases
Suppurative lung diseasesSuppurative lung diseases
Suppurative lung diseases
 
Pneumonia
PneumoniaPneumonia
Pneumonia
 
Hyperventilation syndrome.
Hyperventilation syndrome.Hyperventilation syndrome.
Hyperventilation syndrome.
 
Viral pneumonia
Viral pneumoniaViral pneumonia
Viral pneumonia
 
Churg-Strauss Syndrome
Churg-Strauss SyndromeChurg-Strauss Syndrome
Churg-Strauss Syndrome
 
Approach to a patient with Haemoptysis
Approach to a patient with HaemoptysisApproach to a patient with Haemoptysis
Approach to a patient with Haemoptysis
 
Pleurisy
PleurisyPleurisy
Pleurisy
 
Cough
Cough Cough
Cough
 
Respiratory failure
Respiratory failureRespiratory failure
Respiratory failure
 
Community Acquired Pneumonia
Community Acquired PneumoniaCommunity Acquired Pneumonia
Community Acquired Pneumonia
 
Approach to pleural effusion
Approach to pleural effusionApproach to pleural effusion
Approach to pleural effusion
 
Dysphagia
DysphagiaDysphagia
Dysphagia
 
Childhood Pneumonia 2017, BSMMU, Bangladesh.
Childhood Pneumonia 2017, BSMMU, Bangladesh.Childhood Pneumonia 2017, BSMMU, Bangladesh.
Childhood Pneumonia 2017, BSMMU, Bangladesh.
 
Pneumonia
Pneumonia Pneumonia
Pneumonia
 

Similar to Approach to a case of suppurative lung disease

Upper respiratory disorders and nursing mangement
Upper respiratory disorders and nursing mangementUpper respiratory disorders and nursing mangement
Upper respiratory disorders and nursing mangementANILKUMAR BR
 
Pediatric pneumonia.pptx
Pediatric pneumonia.pptxPediatric pneumonia.pptx
Pediatric pneumonia.pptxDrHananTork
 
approachtorecurrentpneumonia-170523181837.pdf
approachtorecurrentpneumonia-170523181837.pdfapproachtorecurrentpneumonia-170523181837.pdf
approachtorecurrentpneumonia-170523181837.pdfSatyajitNaskar4
 
Approach to recurrent pneumonia
Approach to recurrent pneumoniaApproach to recurrent pneumonia
Approach to recurrent pneumoniaSeema Rai
 
cough-161117122251 (1).pdf
cough-161117122251 (1).pdfcough-161117122251 (1).pdf
cough-161117122251 (1).pdfTabassum Saher
 
Approach to patient with uper and lower airway diseases
Approach to patient with uper and lower airway diseasesApproach to patient with uper and lower airway diseases
Approach to patient with uper and lower airway diseasesTigreentertainment
 
Diptheria (Whooping cough) and Pertussis
Diptheria (Whooping cough) and PertussisDiptheria (Whooping cough) and Pertussis
Diptheria (Whooping cough) and PertussisPinky Rathee
 
cough and dyspnea
cough and dyspneacough and dyspnea
cough and dyspneaAmit Goyal
 
Hoarseness year-4
Hoarseness year-4Hoarseness year-4
Hoarseness year-4Dennis Lee
 
Unit II. Respiratory system disorders.pptx
Unit II.  Respiratory system disorders.pptxUnit II.  Respiratory system disorders.pptx
Unit II. Respiratory system disorders.pptxSani191640
 
Kunal Singh .Topic-4.Diseases of the larynx.ENT.GM20-148.pptx
Kunal Singh .Topic-4.Diseases of the larynx.ENT.GM20-148.pptxKunal Singh .Topic-4.Diseases of the larynx.ENT.GM20-148.pptx
Kunal Singh .Topic-4.Diseases of the larynx.ENT.GM20-148.pptxshiv847105
 
respiratory_assessment_and_disorders_1.ppt
respiratory_assessment_and_disorders_1.pptrespiratory_assessment_and_disorders_1.ppt
respiratory_assessment_and_disorders_1.pptNRS MARYAM I AMINU
 

Similar to Approach to a case of suppurative lung disease (20)

Dry cough
Dry coughDry cough
Dry cough
 
Upper respiratory disorders and nursing mangement
Upper respiratory disorders and nursing mangementUpper respiratory disorders and nursing mangement
Upper respiratory disorders and nursing mangement
 
Pediatric pneumonia.pptx
Pediatric pneumonia.pptxPediatric pneumonia.pptx
Pediatric pneumonia.pptx
 
approachtorecurrentpneumonia-170523181837.pdf
approachtorecurrentpneumonia-170523181837.pdfapproachtorecurrentpneumonia-170523181837.pdf
approachtorecurrentpneumonia-170523181837.pdf
 
Approach to recurrent pneumonia
Approach to recurrent pneumoniaApproach to recurrent pneumonia
Approach to recurrent pneumonia
 
cough-161117122251 (1).pdf
cough-161117122251 (1).pdfcough-161117122251 (1).pdf
cough-161117122251 (1).pdf
 
Cough
CoughCough
Cough
 
Cystic fibrosis
Cystic fibrosis Cystic fibrosis
Cystic fibrosis
 
Approach to patient with uper and lower airway diseases
Approach to patient with uper and lower airway diseasesApproach to patient with uper and lower airway diseases
Approach to patient with uper and lower airway diseases
 
Diptheria (Whooping cough) and Pertussis
Diptheria (Whooping cough) and PertussisDiptheria (Whooping cough) and Pertussis
Diptheria (Whooping cough) and Pertussis
 
cough and dyspnea
cough and dyspneacough and dyspnea
cough and dyspnea
 
Hoarseness year-4
Hoarseness year-4Hoarseness year-4
Hoarseness year-4
 
QPR-COPD
QPR-COPDQPR-COPD
QPR-COPD
 
Unit II. Respiratory system disorders.pptx
Unit II.  Respiratory system disorders.pptxUnit II.  Respiratory system disorders.pptx
Unit II. Respiratory system disorders.pptx
 
Cough
CoughCough
Cough
 
Unit II
Unit IIUnit II
Unit II
 
Kunal Singh .Topic-4.Diseases of the larynx.ENT.GM20-148.pptx
Kunal Singh .Topic-4.Diseases of the larynx.ENT.GM20-148.pptxKunal Singh .Topic-4.Diseases of the larynx.ENT.GM20-148.pptx
Kunal Singh .Topic-4.Diseases of the larynx.ENT.GM20-148.pptx
 
Diptheria & pertussis
Diptheria & pertussisDiptheria & pertussis
Diptheria & pertussis
 
respiratory_assessment_and_disorders_1.ppt
respiratory_assessment_and_disorders_1.pptrespiratory_assessment_and_disorders_1.ppt
respiratory_assessment_and_disorders_1.ppt
 
Asthma
AsthmaAsthma
Asthma
 

Recently uploaded

Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 

Recently uploaded (20)

Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 

Approach to a case of suppurative lung disease

  • 2. Case 1 : A 54-year-old woman presented with chronic cough with thick greenish sputum that has worsened over a period of 6–12 months. Over the course of the day, she estimates that she produces as much as 100 ml of sputum daily. Bilateral coarse crackles are heard in the lower lung zones. Pulmonary function tests demonstrate FEV1/FVC ratio of 56%. A chest radiograph is unremarkable. What would you recommend as the next step in the evaluation and management of this patient?
  • 3. Case 2: A 48-year-old man(chronic alcoholic) presented with fever and cough. He has fever, fatigue and generalized malaise for about 8 weeks. During this period, he has been having increasing cough with foul smelling dark sputum production at least 3 tablespoons daily that has been blood streaked at times. He has evidence of temporal wasting with very poor dentition. A foul odor is present on his breath. Amphoric breath sounds are heard posteriorly in the right lower lung field. What is the best initial choice for therapy in this patient and investigations to be planned ?
  • 4. At the end of this presentation we would be able to: 1. Know the different types of suppurative lung diseases. 2. Describe the etiology and pathogenesis of each type. 3. Describe the clinical features of each disease. 4. Interpret the specific investigations. 5. Discuss the different complications. 6. Discuss the treatment modalities including surgery.
  • 5. The term suppurative lung diseases implies the following:  Bronchiectasis  Lung abscess  Empyema thoracis
  • 6. History Fever, persistent cough with copious sputum production Weeks to months + Risk of aspiration GERD Tooth infections (bad breath) Months to years + h/o recurrent/long standing infections Postural increase in sputum production Congenital defects Autoimmune disorder Rhinosinusitis
  • 7. Examination Auscultation: Wheezing + coarse crepts General : mouth for decaying teeth, gag reflex may be absent. Palpation : increased vocal fremitus Percussion : dullness Auscultation : Amphoric or cavernous sounds General: mouth for decaying teeth Inspection : restricted movement, Crowding of ribs Palpation : tracheal shift ± shifting of apex beat Decreased Vocal fremitus Reduced chest expansion Auscultation Decreased/absent breath sounds Decreased/ absent vocal resonance
  • 8.
  • 9. Bronchiectasis  Abnormal irreversible dilatation of the bronchi (medium sized bronchioles).  Not a disease per se but end stage of a variety of pathological processes.  Extent may focal (localized to an area distal to mechanical bronchial obstruction) or diffuse (systemic pathology).
  • 10.
  • 11. Etiology: I. Post infectious II. Mucociliary abnormalities III. Immunological disorders IV. Mechanical Obstruction
  • 15. Clinical Features: Symptoms: 1. Persistent cough with expectoration 2. Copious thick sputum associated with postural change. 3. Haemoptysis (30%) 4. Dyspnea 5. Chest pain
  • 16. Signs: 1. Crepitations (78%) 2. Wheezes (20%) 3. Signs of pulmonary hypertension or corpulmonale. 4. General: Cyanosis, clubbing(5%)
  • 17. Associated findings supporting the diagnosis Signs and Symptoms suggestive of -  Rhinosinusitis  Gastro-esophageal reflux Disease  Depressed sensorium  Autoimmune disease  Mucociliary defect  ABPA (Allergic Brochopulmonary Aspergillosis)  Primary immunodeficiency
  • 18. Diagnosis and investigations:  Sputum – culture & sensitivity Common organisms: H.Infleunza. S.Pneumoniae. Pseudomonas aeruginosa S.Aureus. Mycobacterium sp.
  • 21. Radiological clues to etiology –  Chronic recurrent aspirations – lower lung fields  MAC infection - middle lung fields  Congenital cilliary defects – middle lung field  Allergic Bronchopulmonary Aspergillosis – central bronchioles  Cystic fibrosis & radiation – upper lung fields
  • 22. Tests for Detecting Specific Aetiologies of Bronchiectasis  Paranasal sinus disease (X-ray or CT paranasal sinuses)  Gastro-oesophageal reflux (barium swallow, esophageal manometry)  Immune deficiency [Total levels of IgG, IgM, IgE and IgA]  ABPA [serum precipitins and sputum for Aspergillus fumigatus]  Connective tissue disorders ( ANA and rheumatoid factor)  α1-antitrypsin deficiency (serum α1-antitrypsin levels)  Cystic fibrosis (sweat chloride analysis, genotyping)  Endobronchial abnormalities (Fibre-optic bronchoscopy)  Ciliary dyskinesias (semen analysis, saccharine test)
  • 23.  Functional impairment : 1. Measurement of ventilatory capacity  Airway obstruction.  Lung volumes and compliance. 2. Gas exchange studies  Decreased DLCO.  Abnormal V/P scan.
  • 24. Treatment Medical Antibiotics Bronchial hygiene Corticosteroids Prevention Surgical
  • 25. Antibiotics Indications: 1. Mucoid sputum  muco-purulent sputum. 2. Chronic muco-purulent or purulent sputum  ↑ amount or purulence, change of color, systemic symptoms or worsening of lung functions.
  • 26. Antibiotic therapy  Start with β lactum antibiotics preferably with pseudomonal coverage.  Add antibiotics according to culture and sensitivity.  Duration – 7-10 days(acute exacerbations) upto 14 days.
  • 27. Bronchial hygiene Aim:  Mobilization of secretions from the lung periphery (or affected area)towards the more central unaffected segments in which cough reflex is intact and mucociliary function is preserved. Approaches :  Hydration and mucolytic administration  Brochodilators  Chest physiotherapy
  • 28. Complications 1. Recurrent pneumonia. 2. Lung abscess. 3. Pneumothorax. 4. Cor pulmonale and pulmonary hypertension 5. Secondary Amyloidosis.
  • 29.
  • 30. Lung Abscess Localized area of destruction of lung parenchyma where pyogenic infection is the cause of tissue necrosis and suppuration.  Primary lung abscesses - arise from aspiration (anaerobic bacteria), absence of an underlying pulmonary or systemic condition.  Secondary lung abscesses – underlying pulmonary condition(postobstructive e.g. a bronchial foreign body or tumor) or a systemic process (e.g., HIV infection or another immunocompromising condition).
  • 31. Primary lung abscess 1. Factors predisposing to aspiration  Dental caries  Impaired consciousness  Anaesthesia (general)  Stroke (cerebro-vascular accident)  Seizures including post-ictal state  Head trauma  Alcohol intoxication  Drug overdose or abuse (narcotics, sedatives)  Metabolic encephalopathy  Neuromuscular diseases
  • 32. 2. Oesophageal disorders  Achalasia and other dysmotility syndromes  Gastro-oesophageal reflux  Stricture (benign or malignant)  Zenker’s diverticulum
  • 33. Clinical features Symptoms: chronic indolent course 1. Fever 2. Cough with expectoration(copious & foul smelling) 3. Chest pain. 4. Hemoptysis. 5. Dyspnea 6. Fatigue, night sweats and anemia.
  • 34. Signs: General: clubbing, mouth for decaying teeth, gag reflex may be absent. Palpation : increased vocal fremitus Percussion : dullness Auscultation :  amphoric or cavernous sounds
  • 36. Aerobic organisms G +ve Strep. melleri Strep. pneum. Staph aureus G –ve Pseudomonas Klebsiella E.coli H.Infleunza
  • 37. Investigations: Microbiological studies: 1. Sputum  Gram stain  Culture 2. Blood culture 3. Specimens for anaerobic culture without oropharyngeal contamination  Transtracheal aspiration  Percutaneus Needle Aspiration  Brochoalveolar lavage
  • 40.  Other investigations 1. Bronchoscopy 2. Upper GI endoscopy
  • 41. Complications 1. Pneumatocoeles (persistent cystic changes) 2. Bronchiectasis 3. Empyema 4. Direct or haematogenous spread. 5. Massive hemoptysis
  • 42. Treatment 1. Antibiotics  Duration - 3-4 weeks( upto 14 weeks) – non tubercular 2. Bronchoscopy 3. Surgery  Abscess > 6 – 8 cm in diameter  Non responders to antibiotic treatment
  • 43. Antibiotics Community acquired Clindamycin Amoxicillin + Clavulanic acid Hospital acquired To cover: G–ve, staph & anaerobe
  • 44.
  • 45. Empyema thoracis  Definition: Pus in the pleural cavity  Etiology: 1.Thoracic & extrathoracic infection 2.Tumour 3.Trauma or iatrogenic
  • 47. Common organisms: 1. Anaerobes 2. Staph. aureus 3. β hemolytic streptococci 4. Pseudomonas, E. coli & Klebsiella spp. 5. Mixed.
  • 48. Clinical picture: Symptoms 1. Fever 2. Malaise 3. Pleuritic chest pain 4. Dyspnea 5. Cough  sputum
  • 49. Signs General: weight loss, clubbing, mouth for decaying teeth Inspection : restricted movement, Crowding of ribs Palpation :  tracheal shift shifting of apex beat  Vocal fremitus  Reduced chest expansion Auscultation  Decreased breadth sounds  Decreased/ absent vocal resonance  No added sounds
  • 50. Investigations: 1. Blood and biochemical exam 2. Chest radiograph 3. CT scan 4. Sputum culture 5. Blood culture 6. Usg guided thoracocenthesis:  Chemistry  Bacteriology  Cytology 8. Bronchoscopy
  • 51.
  • 52. Management (Antibiotics + Drainage) Antibiotics  Same as lung abscess Drainage  10 –20% require external drainage or surgery.
  • 53. Drainage Closed Frank pus ph < 7 Failure to improve Bronchopleural fistula Open drainage with rib resection Decortication
  • 54. Complications  Restrictive defect  Pleural calcifications  Brochopleural fistula  Pleuro-cutaneous fistula  Pleural thickening